REQUEST A DEMO
Total
USD $0.00
Search more companies

Stendhalpharma Ecuador S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Stendhalpharma Ecuador S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Stendhalpharma Ecuador S.A. is based in Ecuador. The head office is in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was incorporated on August 14, 2015. It currently has a total number of 1 (2023) employees. There was a total negative growth of 14.25% in Stendhalpharma Ecuador S.A.’s total assets over the same period.

Headquarters
Paul Rivet 2816, Josueth Gonzalez Bldg. , Floor 10
Quito; Pichincha;

Contact Details: Purchase the Stendhalpharma Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Stendhalpharma Ecuador S.A. report to view the information.
Outstanding Shares:
Purchase the Stendhalpharma Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Stendhalpharma Ecuador S.A. report to view the information.
Incorporation Date:
August 14, 2015
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
30%
Company Performance
Financial values in the chart are available after Stendhalpharma Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
-24.87%
Net Profit (Loss) for the Period
-24.87%
Total assets
-14.25%
Total equity
-2.63%
Return on Equity (ROE)
0.46%
Quick Ratio
-0%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?